Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Pharoah, John Stratton, James Mackay (1998)
Screening for breast and ovarian cancer: the relevance of family history.British medical bulletin, 54 4
G. Narayansingh, K. Chew, D. Parkin (1999)
Role of conventional ovarian screening is questionedBMJ, 318
L. Kasprzak, W. Foulkes, A. Shelling (1999)
Fortnightly review: Hereditary ovarian carcinomaBMJ, 318
V. Seltzer, B. Drukker, B. Gillespie, Lynn Gossfeld, P. Grigsby, H. Harvey, C. Hendricks, S. Hummel, R. Makuch, G. Monaco, G. Parham, C. Sawyers, R. West, D. Alberts, B. Anderson, H. Averette, R. Bast, M. Christian, N. Colombo, W. Creasman, J. Curtin, D. Gershenson, W. Hoskins, B. Karlan, B. Kramer, M. Markman, W. Mcguire, R. Ozols, S. Pecorelli, K. Podratz, J. Thigpen, G. Thomas, C. Trimble, C. Westhoff, A. Whittemore, R. Young, E. Trimble, E. Blume, E. Bray, J. Ferguson, R. Giusti, W. Hall, Charles Harrison, M. McCabe, T. Moore, S. Nayfield, C. Nichols, R. Park, E. Reed, C. Sherman, S. Broder (1995)
Ovarian cancer: screening, treatment, and followup.NIH consensus statement, 12 3
H. Lynch, M. Casey, Trudy Shaw, J. Lynch (1998)
Hereditary Factors in Gynecologic Cancer.The oncologist, 3 5
M. Suchard, P. Yudkin, J. Sinsheimer, G. Fowler (1999)
General practitioners' views on genetic screening for common diseases.The British journal of general practice : the journal of the Royal College of General Practitioners, 49 438
A. Fry, H. Campbell, H. Gudmunsdottir, R. Rush, M. Porteous, D. Gorman, A. Cull (1999)
GPs' views on their role in cancer genetics services and current practice.Family practice, 16 5
A. Herbst (1994)
The epidemiology of ovarian carcinoma and the current status of tumor markers to detect disease.American journal of obstetrics and gynecology, 170 4
S. Kumar (1999)
Resisting revolution: generalism and the new geneticsThe Lancet, 354
E. Eriksson, S. Lauri (2000)
Informational and emotional support for cancer patients' relatives.European journal of cancer care, 9 1
N. Hallowell (1998)
Providing letters to patients. Patients find summary letters useful.BMJ, 316 7147
E. Rosser, J. Hurst, J. Chapman, C. Chapman, Dr Rosser (1996)
Cancer families: what risks are they given and do the risks affect management?Journal of Medical Genetics, 33
Kasprzak Kasprzak, Foulkes Foulkes, Shellin Shellin (1999)
Hereditary ovarian cancer.British Medical Journal, 318
Leide Leide, Tonin Tonin, Sun Sun (1998)
Is hereditary site‐specific ovarian cancer a distinct genetic condition?American Journal of Medical Genetics, 75
JAMA, 273
J. Audrain, B. Rimer, D. Cella, J. Garber, B. Peshkin, Judith Ellis, J. Schildkraut, M. Stefanek, V. Vogel, C. Lerman (1998)
Genetic counseling and testing for breast-ovarian cancer susceptibility: what do women want?Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16 1
F. Douglas, L. O'dair, M. Robinson, D. Evans, S. Lynch (1999)
The accuracy of diagnoses as reported in families with cancer: a retrospective studyJournal of Medical Genetics, 36
P. Rose, Edwina Humm, K. Hey, Linda Jones, S. Huson (1999)
Family history taking and genetic counselling in primary care.Family practice, 16 1
Hallowell Hallowell (1998)
Providing letters to patients.British Medical Journal, 316
In Wales, a cancer genetics service has been developing since 1998. Gynaecologists play an integral role in the management of women with a family history of ovarian cancer and we were interested in investigating referral practice and management for relatives of patients with ovarian cancer among gynaecologists in Wales. In 1999, a postal questionnaire was sent to all gynaecologists. The response rate was 51%. The questionnaire contained structured questions about current provision and a number of hypothetical scenarios to explore referral patterns to the cancer genetics service. The results of this study showed that referrals varied widely among specialists, as did the numbers who required onward referral to cancer genetics. The offer of screening to women at high risk of ovarian cancer was consistent, although there were variations in how often it was offered and the age at which it was offered. Most gynaecologists were easily able to establish when it was appropriate to refer onwards to cancer genetics, differentiating between women at high or low risk. There was some confusion about women at moderate risk of ovarian cancer. This study demonstrated the need for clear referral guidelines in Wales. Guidelines have since been distributed to all general practitioners and specialists; however, continued monitoring and further evaluation of referral practices will be necessary.
European Journal of Cancer Care – Wiley
Published: Sep 1, 2001
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.